Suppr超能文献

无关供者选择评分的开发可预测 HCT 后的生存:供者年龄最重要。

Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most.

机构信息

Center for International Blood and Bone Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.

Center for International Blood and Bone Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wisconsin.

出版信息

Biol Blood Marrow Transplant. 2018 May;24(5):1049-1056. doi: 10.1016/j.bbmt.2018.02.006. Epub 2018 Feb 14.

Abstract

Donor factors, in addition to HLA matching status, have been associated with recipient survival in unrelated donor (URD) hematopoietic cell transplantation (HCT); however, there is no hierarchical algorithm that weights the characteristics of individual donors against each other in a quantitative manner to facilitate donor selection. The goal of this study was to develop and validate a donor selection score that prioritizes donor characteristics associated with better survival in 8/8 HLA-matched URDs. Two separate patient/donor cohorts, the first receiving HCT between 1999 and 2011 (n = 5952, c1), and the second between 2012 and 2014 (n = 4510, c2) were included in the analysis. Both cohorts were randomly spilt, 2:1, into training and testing sets. Despite studying over 10,000 URD transplants, we were unable to validate a donor selection score. The only donor characteristic associated with better survival was younger age, with 2-year survival being 3% better when a donor 10 years younger is selected. These results support previous studies suggesting prioritization of a younger 8/8 HLA-matched donor. This large dataset also shows that none of the other donor clinical factors tested were reproducibly associated with survival, and hence flexibility in selecting URDs based on other characteristics is justified. These data support a simplified URD selection process and have significant implications for URD registries.

摘要

除了 HLA 匹配状态外,供体因素也与无关供体(URD)造血细胞移植(HCT)受者的生存有关;然而,目前尚无一种分层算法可以定量地权衡各个供体的特征,以帮助选择供体。本研究的目的是开发和验证一种供体选择评分系统,该系统优先考虑与 8/8 HLA 匹配的 URD 中更好生存相关的供体特征。该研究纳入了两个独立的患者/供体队列,第一个队列接受 HCT 的时间为 1999 年至 2011 年(n=5952,c1),第二个队列接受 HCT 的时间为 2012 年至 2014 年(n=4510,c2)。这两个队列均被随机分为 2:1 的训练集和测试集。尽管研究了超过 10000 例 URD 移植,但我们仍未能验证供体选择评分系统。唯一与更好生存相关的供体特征是年龄较小,当选择年轻 10 岁的供体时,2 年生存率提高 3%。这些结果支持先前的研究,提示优先选择年轻的 8/8 HLA 匹配供体。该大型数据集还表明,其他经过测试的供体临床因素均未与生存相关,因此基于其他特征灵活选择 URD 是合理的。这些数据支持简化 URD 选择流程,并对 URD 登记处具有重要意义。

相似文献

引用本文的文献

本文引用的文献

8
High HLA-DP Expression and Graft-versus-Host Disease.高HLA-DP表达与移植物抗宿主病
N Engl J Med. 2015 Aug 13;373(7):599-609. doi: 10.1056/NEJMoa1500140.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验